Healios K.K.
$1.8000
12
-$0.90-33.33% Monday 20:00
Statistics
Day High
2.7
Day Low
2.7
52W High
4.45
52W Low
1.8
Volume
100
Avg. Volume
33
Mkt Cap
197.01M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18AugExpected
Expected EPS
-0.015028999804
Actual EPS
N/A
Financials
-773.54%Profit Margin
Unprofitable7.38MRevenue
-57.11MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow HLOSF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Mesoblast
MESO
Mkt Cap1.86B
Biolife Solutions
BLFS
Mkt Cap1.28B
CRISPR Therapeutics
CRSP
Mkt Cap5.33B
Editas Medicine
EDIT
Mkt Cap412.81M
Intellia Therapeutics
NTLA
Mkt Cap2.19B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.57B
Sangamo Therapeutics
SGMO
Mkt Cap70.43M
About
Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051, which is preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is preparing for phase 3 clinical trial for the treatment of ischemic stroke; and HLCM051, which is in phase 2 clinical trial for the treatment of trauma, as well as HLCR011, which is in phase 1/2 clinical trial for the treatment of retinal pigmen epithelium and age-related macular degeneration and AKT-01/HLCN061, which is in pre-clinical trial for the treatment of Mesothelioma, Lung cancer, Hepatocellular carcinoma and Gastric cancer(solid tumors). It also develops somatic stem cell and induced pluripotent stem cell regenerative medicines. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Chiyoda, Japan.
Show more...
CEO
Dr. Tadahisa S. Kagimoto M.D.
Employees
65
Country
Japan
ISIN
JP3835100003
Listings
0 Comments
Share your thoughts
FAQ
What is Healios K.K. stock price today?▼
The current price of HLOSF is $1.80 USD — it has decreased by -33.33% in the past 24 hours. Watch Healios K.K. stock price performance more closely on the chart.
What is Healios K.K. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Healios K.K. stocks are traded under the ticker HLOSF.
Is Healios K.K. stock price growing?▼
HLOSF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Healios K.K. has showed a -43.22% decrease.
What is Healios K.K. market cap?▼
Today Healios K.K. has the market capitalization of 197.01M
When is the next Healios K.K. earnings date?▼
Healios K.K. is going to release the next earnings report on August 18, 2026.
What were Healios K.K. earnings last quarter?▼
HLOSF earnings for the last quarter are -0.17 USD per share, whereas the estimation was -0.07 USD resulting in a -148.2% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Healios K.K. revenue for the last year?▼
Healios K.K. revenue for the last year amounts to 7.38M USD.
What is Healios K.K. net income for the last year?▼
HLOSF net income for the last year is -57.11M USD.
How many employees does Healios K.K. have?▼
As of June 25, 2026, the company has 65 employees.
In which sector is Healios K.K. located?▼
Healios K.K. operates in the Health & Wellness sector.
When did Healios K.K. complete a stock split?▼
Healios K.K. has not had any recent stock splits.
Where is Healios K.K. headquartered?▼
Healios K.K. is headquartered in Chiyoda, Japan.